Literature DB >> 16033370

Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis.

Timothy Bevis1, Ramakrishna Ratnakaram, M Fran Smith, M Tariq Bhatti.   

Abstract

Giant cell arteritis (GCA) can be a devastating disease resulting in blindness if not promptly diagnosed and treated. The only proven treatment for GCA is systemic corticosteroids; however, there are many side-effects associated with this therapy including ocular side-effects such as ocular hypertension, cataract formation and central serous chorioretinopathy. To raise physician awareness, a patient with biopsy-proven GCA is reported who lost vision during corticosteroid therapy because of central serous chorioretinopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033370     DOI: 10.1111/j.1442-9071.2005.01017.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  4 in total

1.  Recurrent Central Serous Chorioretinopathy with Dexamethasone Eye Drop used Nasally for Rhinitis.

Authors:  Gunjan Prakash; Jain Shephali; Nath Tirupati; Pandey D Ji
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

2.  Temporal Association between Topical Ophthalmic Corticosteroid and the Risk of Central Serous Chorioretinopathy.

Authors:  Yuh-Shin Chang; Shih-Feng Weng; Jhi-Joung Wang; Ren-Long Jan
Journal:  Int J Environ Res Public Health       Date:  2020-12-17       Impact factor: 3.390

Review 3.  Choroidal involvement in systemic vasculitis: a systematic review.

Authors:  Pınar Çakar Özdal; Ilknur Tugal-Tutkun
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-04-04

4.  Steroid induced central serous chorioretinopathy in giant cell arteritis.

Authors:  Andre Grixti; Vineeth Kumar
Journal:  Case Rep Ophthalmol Med       Date:  2013-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.